{"id":"W2803611443","doi":"10.1007/s10637-018-0600-2","title":"Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer","year":2018,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; MEK inhibitor; Adverse effect; Internal medicine; Rash; Cancer; Gastroenterology; Progressive disease; Response Evaluation Criteria in Solid Tumors; KRAS; Population; Pharmacokinetics; Nausea; Oncology; MAPK/ERK pathway; Chemotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001247452,0.0007561428,0.001689216,0.0004129921,0.0003934501,0.000816528,0.0003984717,0.0006382257,0.003663318],"category_scores_gemma":[0.0008551214,0.0004486869,0.001414823,0.0005277905,0.0004209354,0.0006575142,0.0003471824,0.001990461,0.0004756566],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001107777,"about_ca_system_score_gemma":0.001533745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001874908,"about_ca_topic_score_gemma":0.007974121,"domain_scores_codex":[0.999594,0.0002054616,0.00002516599,0.00004499142,0.00003409481,0.0000963284],"domain_scores_gemma":[0.999598,0.00006567912,0.00007455406,0.00003211929,0.0000521617,0.0001774803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7611564,0.02175542,0.02175731,0.002563916,0.004368711,0.0002385639,0.0002299874,0.001712929,0.02835396,0.0004108802,0.007348941,0.1501029],"study_design_scores_gemma":[0.5054314,0.397485,0.06425645,0.0002029328,0.003608875,0.0006321354,0.0002090586,0.0009664461,0.009151188,0.0003668798,0.01762366,0.0000658702],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772553,0.01419559,0.0003217614,0.0009224563,0.0002019966,0.001232482,0.002359446,0.00004193109,0.003469056],"genre_scores_gemma":[0.9807718,0.009704937,0.000990627,0.001051424,0.000147262,0.001011319,0.003380348,0.00001920793,0.002923006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003663318,"threshold_uncertainty_score":0.01225507,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02750770921311321,"score_gpt":0.2988648976050661,"score_spread":0.2713571883919529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}